Deaths from hepatocellular carcinoma are more likely to occur in medical facilities than deaths from other cancers: 2003-2018

Katie Truitt; Sadiya S. Khan; Dyanna L. Gregory; Sarah Chuzi; Lisa B. VanWagner

doi:10.1111/liv.14915

Deaths from hepatocellular carcinoma are more likely to occur in medical facilities than deaths from other cancers: 2003-2018

Katie Truitt, Sadiya S. Khan, Dyanna L. Gregory, Sarah Chuzi, Lisa B. VanWagner^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Place of death is a key indicator of quality of end-of-life care, and most people with a terminal diagnosis prefer to die at home. Home has surpassed the hospital as the most common location of all-cause and total cancer-related deaths in the United States. However, trends in place of death due to hepatocellular carcinoma (HCC), which is uniquely comanaged by hepatologists and oncologists, have not been described. We analysed US death certificate data from 2003 to 2018 for the proportion of deaths over time at medical facilities, nursing facilities, hospice facilities and home, for HCC and non-HCC cancer. The proportion of deaths increased from 0.6% to 15.2% in hospice facilities (P trend < 0.0001) but did not change at home. In multivariable analysis, persons with HCC were more likely than persons with non-HCC cancer to die in medical facilities, while persons with HCC were less likely to die at home.

Original language	English (US)
Pages (from-to)	1489-1493
Number of pages	5
Journal	Liver International
Volume	41
Issue number	7
DOIs	https://doi.org/10.1111/liv.14915
State	Published - Jul 2021

Funding

LBV is supported by the National Heart, Lung and Blood Institute at the National Institutes of Health (grant number, K23 HL136891). SSK is supported by the National Institutes of Health (grant numbers, P30AG059988; P30DK092939) and the American Heart Association (grant number, #19TPA34890060). LBV receives investigator‐initiated grant support and is a consultant for WL Gore & Associates, consults for Noble Insights, Inc, consults for Gerson Lehrman Group and serves as an expert witness for the Expert Institute outside of the submitted work. The remaining authors have nothing to disclose. LBV is supported by the National Heart, Lung and Blood Institute at the National Institutes of Health (grant number, K23 HL136891). SSK is supported by the National Institutes of Health (grant numbers, P30AG059988; P30DK092939) and the American Heart Association (grant number, #19TPA34890060). LBV receives investigator-initiated grant support and is a consultant for WL Gore & Associates, consults for Noble Insights, Inc, consults for Gerson Lehrman Group and serves as an expert witness for the Expert Institute outside of the submitted work. The remaining authors have nothing to disclose.

Keywords

hepatocellular carcinoma
palliative care
place of death
terminal care

ASJC Scopus subject areas

Hepatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/liv.14915

Cite this

@article{0430b9062fb2480d8b8724ab4d3b3f1d,

title = "Deaths from hepatocellular carcinoma are more likely to occur in medical facilities than deaths from other cancers: 2003-2018",

abstract = "Place of death is a key indicator of quality of end-of-life care, and most people with a terminal diagnosis prefer to die at home. Home has surpassed the hospital as the most common location of all-cause and total cancer-related deaths in the United States. However, trends in place of death due to hepatocellular carcinoma (HCC), which is uniquely comanaged by hepatologists and oncologists, have not been described. We analysed US death certificate data from 2003 to 2018 for the proportion of deaths over time at medical facilities, nursing facilities, hospice facilities and home, for HCC and non-HCC cancer. The proportion of deaths increased from 0.6% to 15.2% in hospice facilities (P trend < 0.0001) but did not change at home. In multivariable analysis, persons with HCC were more likely than persons with non-HCC cancer to die in medical facilities, while persons with HCC were less likely to die at home.",

keywords = "hepatocellular carcinoma, palliative care, place of death, terminal care",

author = "Katie Truitt and Khan, {Sadiya S.} and Gregory, {Dyanna L.} and Sarah Chuzi and VanWagner, {Lisa B.}",

note = "Funding Information: LBV is supported by the National Heart, Lung and Blood Institute at the National Institutes of Health (grant number, K23 HL136891). SSK is supported by the National Institutes of Health (grant numbers, P30AG059988; P30DK092939) and the American Heart Association (grant number, #19TPA34890060). LBV receives investigator‐initiated grant support and is a consultant for WL Gore & Associates, consults for Noble Insights, Inc, consults for Gerson Lehrman Group and serves as an expert witness for the Expert Institute outside of the submitted work. The remaining authors have nothing to disclose. Funding Information: LBV is supported by the National Heart, Lung and Blood Institute at the National Institutes of Health (grant number, K23 HL136891). SSK is supported by the National Institutes of Health (grant numbers, P30AG059988; P30DK092939) and the American Heart Association (grant number, #19TPA34890060). LBV receives investigator-initiated grant support and is a consultant for WL Gore & Associates, consults for Noble Insights, Inc, consults for Gerson Lehrman Group and serves as an expert witness for the Expert Institute outside of the submitted work. The remaining authors have nothing to disclose. Publisher Copyright: {\textcopyright} 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd",

year = "2021",

month = jul,

doi = "10.1111/liv.14915",

language = "English (US)",

volume = "41",

pages = "1489--1493",

journal = "Liver International",

issn = "1478-3223",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "7",

}

TY - JOUR

T1 - Deaths from hepatocellular carcinoma are more likely to occur in medical facilities than deaths from other cancers

T2 - 2003-2018

AU - Truitt, Katie

AU - Khan, Sadiya S.

AU - Gregory, Dyanna L.

AU - Chuzi, Sarah

AU - VanWagner, Lisa B.

N1 - Funding Information: LBV is supported by the National Heart, Lung and Blood Institute at the National Institutes of Health (grant number, K23 HL136891). SSK is supported by the National Institutes of Health (grant numbers, P30AG059988; P30DK092939) and the American Heart Association (grant number, #19TPA34890060). LBV receives investigator‐initiated grant support and is a consultant for WL Gore & Associates, consults for Noble Insights, Inc, consults for Gerson Lehrman Group and serves as an expert witness for the Expert Institute outside of the submitted work. The remaining authors have nothing to disclose. Funding Information: LBV is supported by the National Heart, Lung and Blood Institute at the National Institutes of Health (grant number, K23 HL136891). SSK is supported by the National Institutes of Health (grant numbers, P30AG059988; P30DK092939) and the American Heart Association (grant number, #19TPA34890060). LBV receives investigator-initiated grant support and is a consultant for WL Gore & Associates, consults for Noble Insights, Inc, consults for Gerson Lehrman Group and serves as an expert witness for the Expert Institute outside of the submitted work. The remaining authors have nothing to disclose. Publisher Copyright: © 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd

PY - 2021/7

Y1 - 2021/7

N2 - Place of death is a key indicator of quality of end-of-life care, and most people with a terminal diagnosis prefer to die at home. Home has surpassed the hospital as the most common location of all-cause and total cancer-related deaths in the United States. However, trends in place of death due to hepatocellular carcinoma (HCC), which is uniquely comanaged by hepatologists and oncologists, have not been described. We analysed US death certificate data from 2003 to 2018 for the proportion of deaths over time at medical facilities, nursing facilities, hospice facilities and home, for HCC and non-HCC cancer. The proportion of deaths increased from 0.6% to 15.2% in hospice facilities (P trend < 0.0001) but did not change at home. In multivariable analysis, persons with HCC were more likely than persons with non-HCC cancer to die in medical facilities, while persons with HCC were less likely to die at home.

AB - Place of death is a key indicator of quality of end-of-life care, and most people with a terminal diagnosis prefer to die at home. Home has surpassed the hospital as the most common location of all-cause and total cancer-related deaths in the United States. However, trends in place of death due to hepatocellular carcinoma (HCC), which is uniquely comanaged by hepatologists and oncologists, have not been described. We analysed US death certificate data from 2003 to 2018 for the proportion of deaths over time at medical facilities, nursing facilities, hospice facilities and home, for HCC and non-HCC cancer. The proportion of deaths increased from 0.6% to 15.2% in hospice facilities (P trend < 0.0001) but did not change at home. In multivariable analysis, persons with HCC were more likely than persons with non-HCC cancer to die in medical facilities, while persons with HCC were less likely to die at home.

KW - hepatocellular carcinoma

KW - palliative care

KW - place of death

KW - terminal care

UR - http://www.scopus.com/inward/record.url?scp=85105477447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85105477447&partnerID=8YFLogxK

U2 - 10.1111/liv.14915

DO - 10.1111/liv.14915

M3 - Article

C2 - 33932082

AN - SCOPUS:85105477447

SN - 1478-3223

VL - 41

SP - 1489

EP - 1493

JO - Liver International

JF - Liver International

IS - 7

ER -

Deaths from hepatocellular carcinoma are more likely to occur in medical facilities than deaths from other cancers: 2003-2018

Abstract

Funding

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this